Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 3/20 | 0.45 |
| ▸ | AKT2 | P31751 | 1/20 | 0.45 |
| ▸ | AOC3 | Q16853 | 10/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 7/20 | 0.42 |
| ▸ | CNR1 | P21554 | 2/20 | 0.40 |
| ▸ | CNR2 | P34972 | 2/20 | 0.40 |
| ▸ | KIT | P10721 | 1/20 | 0.36 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.36 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.36 |
| ▸ | NTRK3 | Q16288 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14977671 | 0.93 | AKT1 (0.45) | AKT1AKT2AOC3KCNH2CNR1 | |
| SCHEMBL14976448 | 0.85 | AKT1 (0.43) | AKT1AKT2CNR1CNR2KIT | |
| SCHEMBL14977636 | 0.83 | AKT1 (0.48) | AKT1AKT2CNR1CNR2KIT | |
| SCHEMBL14976591 | 0.82 | AKT1 (0.46) | AKT1AKT2CNR1CNR2KIT | |
| SCHEMBL14976175 | 0.82 | CNR1 (0.44) | AKT1AKT2CNR1CNR2KIT | |
| SCHEMBL14975461 | 0.82 | AKT1 (0.43) | AKT1AKT2CNR1CNR2KIT | |
| SCHEMBL14977316 | 0.81 | AKT1 (0.47) | AKT1AKT2CNR1CNR2KIT | |
| SCHEMBL14976132 | 0.81 | AKT1 (0.44) | AKT1AKT2CNR1CNR2KIT | |
| SCHEMBL14977463 | 0.79 | ROCK2 (0.42) | AKT1AKT2CNR1CNR2KIT | |
| SCHEMBL14976118 | 0.79 | AKT1 (0.41) | AKT1AKT2CNR1CNR2KIT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013078254-A1 | BICYCLIC HETEROARYL DERIVATIVES AS KINASE INHIBITORS | ARRAY BIOPHARMA INC. (US) | 2013-05-30 | — | — | WO | disclosed |